STOCK TITAN

Guardant Health (GH) CIO reports RSU vesting and tax share withholding

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Guardant Health, Inc. Chief Information Officer Kumud Kalia reported routine equity compensation activity. On 2026-07-01, several batches of restricted stock units vested and were converted into a total of 6,046 shares of common stock at a conversion price of $0.00 per share.

To cover associated tax obligations from this vesting, 3,066 shares of common stock were withheld by the company at a value of $170.77 per share, as described in the footnotes. These transactions reflect compensation-related vesting and tax withholding rather than open-market buying or selling.

Positive

  • None.

Negative

  • None.
Insider Kalia Kumud
Role Chief Information Officer
Type Security Shares Price Value
Exercise Restricted Stock Units 1,607 $0.00 --
Exercise Restricted Stock Units 1,084 $0.00 --
Exercise Restricted Stock Units 1,994 $0.00 --
Exercise Restricted Stock Units 1,361 $0.00 --
Exercise Common Stock 1,607 $0.00 --
Exercise Common Stock 1,084 $0.00 --
Exercise Common Stock 1,994 $0.00 --
Exercise Common Stock 1,361 $0.00 --
Tax Withholding Common Stock 3,066 $170.77 $524K
Holdings After Transaction: Restricted Stock Units — 1,607 shares (Direct, null); Common Stock — 42,421 shares (Direct, null)
Footnotes (1)
  1. These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. Not applicable for Restricted Stock Units. This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.
Shares withheld for taxes 3,066 shares Common stock withheld to meet tax obligations
Withholding price per share $170.77/share Value applied to 3,066 withheld shares
RSU shares vested 6,046 shares Total common shares from RSU exercises
Acquire transactions 8 transactions Derivative exercises/conversions on 2026-07-01
Dispose transactions 1 transaction Tax-withholding disposition of common stock
Tax withholding shares 3,066 shares Shares retained by company for RSU tax liability
Exercise transactions 4 exercises RSU-related derivative exercises
Net buy/sell direction Neutral transactionSummary netBuySellDirection
Restricted Stock Units financial
"This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder"
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Chief Information Officer financial
"officer_title: Chief Information Officer"
A chief information officer (CIO) is a senior executive responsible for managing a company's technology and information systems. They ensure that technology supports the organization’s goals, much like a conductor coordinating an orchestra to create harmonious music. Investors care about CIOs because their decisions and strategies can influence a company's efficiency, security, and ability to adapt to new digital opportunities.
installment financial
"in connection with the vesting of an installment of the restricted stock units"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kalia Kumud

(Last)(First)(Middle)
3100 HANOVER STREET

(Street)
PALO ALTO CALIFORNIA 94304

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Information Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/01/2026M1,607A$042,421D
Common Stock07/01/2026M1,084A$043,505D
Common Stock07/01/2026M1,994A$045,499D
Common Stock07/01/2026M1,361A$046,860D
Common Stock07/01/2026F3,066(1)D$170.7743,794D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units$007/01/2026M1,607 (2) (3)Common Stock1,607$01,607D
Restricted Stock Units$007/01/2026M1,084 (4) (3)Common Stock1,084$01,084D
Restricted Stock Units$007/01/2026M1,994 (5) (3)Common Stock1,994$09,973D
Restricted Stock Units$007/01/2026M1,361 (6) (3)Common Stock1,361$09,522D
Explanation of Responses:
1. These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
2. This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
3. Not applicable for Restricted Stock Units.
4. This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
5. This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
6. This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.
Remarks:
/s/ John G. Saia, as attorney-in-fact for Kumud Kalia07/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Guardant Health (GH) executive Kumud Kalia report in this Form 4?

Kumud Kalia, Chief Information Officer of Guardant Health, reported the vesting of restricted stock units converting into 6,046 common shares and the withholding of 3,066 shares to satisfy tax obligations related to that vesting. These are compensation-related, not open-market, transactions.

Were any Guardant Health (GH) shares bought or sold on the open market?

No open-market purchases or sales were reported. The Form 4 shows derivative exercises of restricted stock units and a tax-withholding disposition, where the company retained 3,066 shares to cover withholding obligations tied to the RSU vesting event.

How many Guardant Health (GH) shares vested for Kumud Kalia in this filing?

Restricted stock units converting into a total of 6,046 common shares vested for Kumud Kalia. These shares came from multiple RSU awards that vest over multi-year schedules, as detailed in the footnotes describing grant and vesting timelines from 2022 through 2025.

Why were 3,066 Guardant Health (GH) shares withheld in this Form 4?

The company retained 3,066 common shares to meet Kalia’s tax withholding obligations arising from RSU vesting. The footnote states the retained amount was not in excess of the tax liability, indicating a standard tax-settlement mechanism rather than a discretionary sale.

What types of securities are involved in Kumud Kalia’s Guardant Health (GH) transactions?

The filing involves Restricted Stock Units that converted into common stock and the resulting common shares themselves. RSUs are equity awards that vest over time, and upon vesting they deliver common shares, as reflected by the derivative and non-derivative entries.

Do the vesting schedules in the footnotes affect future Guardant Health (GH) share deliveries?

Yes. Footnotes describe several RSU grants from 2022 to 2025 that vest over three to four years, with portions vesting on specific dates and the remainder in equal quarterly installments. These schedules indicate potential future share deliveries as remaining installments vest.